FR2376846B1 - - Google Patents

Info

Publication number
FR2376846B1
FR2376846B1 FR7800616A FR7800616A FR2376846B1 FR 2376846 B1 FR2376846 B1 FR 2376846B1 FR 7800616 A FR7800616 A FR 7800616A FR 7800616 A FR7800616 A FR 7800616A FR 2376846 B1 FR2376846 B1 FR 2376846B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7800616A
Other languages
French (fr)
Other versions
FR2376846A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of FR2376846A1 publication Critical patent/FR2376846A1/fr
Application granted granted Critical
Publication of FR2376846B1 publication Critical patent/FR2376846B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7800616A 1977-01-11 1978-01-09 Nouveaux derives de la piperidine Granted FR2376846A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB931/77A GB1542823A (en) 1977-01-11 1977-01-11 Piperidine derivatives

Publications (2)

Publication Number Publication Date
FR2376846A1 FR2376846A1 (fr) 1978-08-04
FR2376846B1 true FR2376846B1 (ar) 1983-02-04

Family

ID=9713045

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7800616A Granted FR2376846A1 (fr) 1977-01-11 1978-01-09 Nouveaux derives de la piperidine

Country Status (22)

Country Link
JP (1) JPS5387367A (ar)
BE (1) BE862769A (ar)
BG (1) BG28574A3 (ar)
CA (1) CA1101426A (ar)
CS (1) CS195652B2 (ar)
DD (1) DD134089A5 (ar)
DE (1) DE2800919A1 (ar)
DK (1) DK5778A (ar)
ES (1) ES465861A1 (ar)
FI (1) FI780028A (ar)
FR (1) FR2376846A1 (ar)
GB (1) GB1542823A (ar)
IL (1) IL53766A0 (ar)
IT (1) IT1103117B (ar)
LU (1) LU78839A1 (ar)
NL (1) NL7800146A (ar)
NO (1) NO780040L (ar)
PL (1) PL203912A1 (ar)
PT (1) PT67511B (ar)
SE (1) SE7800184L (ar)
SU (2) SU772482A3 (ar)
ZA (1) ZA78158B (ar)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650874A (en) * 1984-11-26 1987-03-17 G. D. Searle & Co. N-(aralkoxybenzyl)-4(benzhydryl) piperidines
US4628095A (en) * 1985-06-05 1986-12-09 G. D. Searle & Co. Substituted N-benzyl-4-(benzhydryl) piperidines
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
WO1997022583A1 (de) * 1995-12-20 1997-06-26 Eckhart Pein Neue 1-phenylalkyl/alkylen-4-(.alpha.-hydroxydiphenylmethyl)-piperidin derivate und ihre verwendung als serotonin antagonisten
DE69924467T2 (de) 1998-01-16 2006-02-16 Eisai Co., Ltd. Verfahren zur herstellung von donepezilderivaten
CN100384421C (zh) * 2002-12-18 2008-04-30 拜尔农科股份公司 N-(取代的芳基甲基)-4-(二取代的甲基)哌啶和吡啶
EP1626044A4 (en) * 2003-05-20 2008-08-20 Ajinomoto Kk NEW PIPERIDINE DERIVATIVE

Also Published As

Publication number Publication date
SE7800184L (sv) 1978-07-12
PT67511A (fr) 1978-02-01
JPS5387367A (en) 1978-08-01
NL7800146A (nl) 1978-07-13
LU78839A1 (fr) 1978-09-18
IT7847573A0 (it) 1978-01-10
GB1542823A (en) 1979-03-28
CS195652B2 (en) 1980-02-29
SU772482A3 (ru) 1980-10-15
ZA78158B (en) 1978-10-25
IL53766A0 (en) 1978-04-30
BG28574A3 (en) 1980-05-15
CA1101426A (en) 1981-05-19
ES465861A1 (es) 1978-09-16
SU990761A1 (ru) 1983-01-23
DD134089A5 (de) 1979-02-07
FI780028A (fi) 1978-07-12
FR2376846A1 (fr) 1978-08-04
NO780040L (no) 1978-07-12
BE862769A (fr) 1978-07-10
PL203912A1 (pl) 1979-06-04
JPS6125031B2 (ar) 1986-06-13
IT1103117B (it) 1985-10-14
PT67511B (fr) 1979-06-11
DE2800919A1 (de) 1978-07-13
DK5778A (da) 1978-07-12

Similar Documents

Publication Publication Date Title
FR2377668B1 (ar)
FR2377087B1 (ar)
DE2712300C2 (ar)
AU495917B2 (ar)
AR210643A1 (ar)
AU71461S (ar)
BE851449A (ar)
BE865722A (ar)
BE866391A (ar)
BE868323A (ar)
BE870787A (ar)
BE871419A (ar)
BE871991A (ar)
BE872973A (ar)
BE873002A (ar)
BG23438A1 (ar)
BG23462A1 (ar)
BG24331A1 (ar)
BG24713A1 (ar)
BG25808A1 (ar)
BG25809A1 (ar)
BG25810A1 (ar)
BG25811A1 (ar)
BG25812A1 (ar)
BG25813A1 (ar)

Legal Events

Date Code Title Description
ST Notification of lapse